The U.S. Food and Drug Administration (FDA) is warning that over-the-counter (OTC) oral drug products containing benzocaine should not be used to treat infants and children younger than 2 years. The risk of a serious and potentially fatal blood disorder prompted FDA action on OTC oral benzocaine products used for teething and mouth pain and prescription local anesthetics.
Visit the FDA website for more information.